CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,800 enrolled
Drug / intervention
Anti-vaping and anti-smoking digital advertisingbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04867668
NCT04867668N/ACompleted

Digital Media for Cancer Control: Randomized Controlled Trial and Dose-Response Effects

George Washington University·interventional·Posted Apr 30, 2021·Updated Mar 10, 2026

In Brief

A clinical study evaluating Anti-vaping and anti-smoking digital advertising for Tobacco Use. Completed, enrolled 2,800 participants across 1 site.

Detailed Summary

There is little published data on exposure to and evaluations of large-scale, online tobacco control campaigns. This project addresses the gap. Under 2 specific aims, the investigators will identify the independent effects of varying levels of digital message exposure to promote anti-tobacco attitudes, beliefs, or behaviors among youth and young adults, first through a randomized experiment online, and second through a field-based evaluation. These studies will advance the science of digital health and have wide application to future campaigns.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Use
CountriesUnited States

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedApr 30, 2021
Enrollment StartFeb 20, 2021
Primary CompletionFeb 28, 2026
TodayJul 2, 2026
Enrollment to primary: 5.0 yearsPosted 5.2 years ago

Interventions

Anti-vaping and anti-smoking digital advertisingbehavioral

Delivery of social media based advertising to prevent vaping and smoking among young adults ages 18-24.